UBE2N and cancer: We also observed an additive effect of HU and UBC13i (Supplementary Figure S5F), suggesting that the UBC13-dependent fork recovery pathway might be targeted to preferentially sensitize BRCA1-deficient cancer cells to replication stress inducers.